DK1710250T3 - Fremgangsmåde til fremstilling af humanserumalbumin ved varnebehandling i tilstedeværelse af divalt kation - Google Patents

Fremgangsmåde til fremstilling af humanserumalbumin ved varnebehandling i tilstedeværelse af divalt kation

Info

Publication number
DK1710250T3
DK1710250T3 DK05703875T DK05703875T DK1710250T3 DK 1710250 T3 DK1710250 T3 DK 1710250T3 DK 05703875 T DK05703875 T DK 05703875T DK 05703875 T DK05703875 T DK 05703875T DK 1710250 T3 DK1710250 T3 DK 1710250T3
Authority
DK
Denmark
Prior art keywords
serum albumin
human serum
ion
preparation
varnish treatment
Prior art date
Application number
DK05703875T
Other languages
Danish (da)
English (en)
Inventor
Kazuyuki Nakashima
Tetsurou Tanabe
Yoshinobu Miyatsu
Hiroshi Mizokami
Shinichi Shibata
Original Assignee
Chemo Sero Therapeut Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemo Sero Therapeut Res Inst filed Critical Chemo Sero Therapeut Res Inst
Application granted granted Critical
Publication of DK1710250T3 publication Critical patent/DK1710250T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/30—Extraction; Separation; Purification by precipitation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK05703875T 2004-01-20 2005-01-20 Fremgangsmåde til fremstilling af humanserumalbumin ved varnebehandling i tilstedeværelse af divalt kation DK1710250T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004012054 2004-01-20
PCT/JP2005/000647 WO2005068489A1 (fr) 2004-01-20 2005-01-20 Procede de production d'albumine serique humaine par chauffage en presence de cation divalent

Publications (1)

Publication Number Publication Date
DK1710250T3 true DK1710250T3 (da) 2009-07-06

Family

ID=34792362

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05703875T DK1710250T3 (da) 2004-01-20 2005-01-20 Fremgangsmåde til fremstilling af humanserumalbumin ved varnebehandling i tilstedeværelse af divalt kation

Country Status (11)

Country Link
US (1) US7531631B2 (fr)
EP (1) EP1710250B1 (fr)
JP (1) JP4644604B2 (fr)
KR (1) KR20070020204A (fr)
CN (1) CN1934128B (fr)
AT (1) ATE428722T1 (fr)
AU (1) AU2005205314B2 (fr)
CA (1) CA2559379A1 (fr)
DE (1) DE602005013912D1 (fr)
DK (1) DK1710250T3 (fr)
WO (1) WO2005068489A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004078965A1 (fr) * 2003-03-05 2004-09-16 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Procede de production d'une proteine etrangere dans escherichia coli
WO2007035283A1 (fr) * 2005-09-15 2007-03-29 Wyeth Floculation de proteines au moyen de sels
JP4936272B2 (ja) * 2006-02-13 2012-05-23 独立行政法人科学技術振興機構 バイオナノカプセルの効率的な精製法
CA2752729A1 (fr) 2009-02-20 2010-08-26 Ventria Bioscience Milieu de culture cellulaire contenant des combinaisons de proteines
KR101933952B1 (ko) 2011-07-01 2018-12-31 가부시키가이샤 한도오따이 에네루기 켄큐쇼 발광 장치, 전자 기기 및 조명 장치
WO2014098464A1 (fr) * 2012-12-18 2014-06-26 이화여자대학교 산학협력단 Composition de stabilisation de la chaleur d'albumine de sérum humain et procédé de production d'albumine de sérum humain à chaleur stabilisée l'utilisant
JP6182465B2 (ja) * 2014-01-29 2017-08-16 シスメックス株式会社 ペプチドの回収方法
KR102573478B1 (ko) 2016-10-04 2023-09-04 알부메딕스 리미티드 재조합 효모-유래 혈청 알부민의 용도
CN106749623B (zh) * 2016-12-09 2020-04-10 浙江大学 一种基于混合模式的扩张床吸附分离人血白蛋白方法
EP4069200A1 (fr) 2019-12-04 2022-10-12 Albumedix Ltd Procédés et compositions produites par ceux-ci
US11739166B2 (en) 2020-07-02 2023-08-29 Davol Inc. Reactive polysaccharide-based hemostatic agent

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL66614A (en) 1981-08-28 1985-09-29 Genentech Inc Method of constructing a dna sequence encoding a polypeptide,microbial production of human serum albumin,and pharmaceutical compositions comprising it
US4775622A (en) 1982-03-08 1988-10-04 Genentech, Inc. Expression, processing and secretion of heterologous protein by yeast
JPH0671434B2 (ja) 1989-09-18 1994-09-14 株式会社ミドリ十字 ヒト血清アルブミンの製造方法
JPH07102148B2 (ja) * 1992-05-20 1995-11-08 株式会社ミドリ十字 遺伝子操作により得られるヒト血清アルブミンの製造方法、およびそれにより得られるヒト血清アルブミン含有組成物
JP2869417B2 (ja) 1992-09-22 1999-03-10 吉富製薬株式会社 遺伝子操作により得られるヒト血清アルブミン
US5440018A (en) 1992-05-20 1995-08-08 The Green Cross Corporation Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same
US5728553A (en) 1992-09-23 1998-03-17 Delta Biotechnology Limited High purity albumin and method of producing
JPH07126182A (ja) 1993-10-27 1995-05-16 Green Cross Corp:The 組換えヒト血清アルブミン製剤の滅菌方法
JP2885212B2 (ja) * 1997-01-06 1999-04-19 吉富製薬株式会社 遺伝子操作由来のヒト血清アルブミンより得られる高純度ヒト血清アルブミン含有組成物
EP0886322A3 (fr) 1997-06-16 1999-02-03 Eastman Kodak Company Encapsulation de capteurs d'images
KR100252052B1 (ko) 1997-12-03 2000-04-15 윤종용 셀 테스트 패턴을 사용하여 강유전체 기억소자의 특성을 평가하는 방법
JP4798833B2 (ja) * 2000-10-24 2011-10-19 一般財団法人化学及血清療法研究所 加熱処理工程を含むヒト血清アルブミンの製造方法
JP4060639B2 (ja) 2002-05-15 2008-03-12 日本電信電話株式会社 データ管理装置
JP5292993B2 (ja) 2008-08-20 2013-09-18 株式会社Ｉｈｉ 鋼床版

Also Published As

Publication number Publication date
JPWO2005068489A1 (ja) 2007-12-27
CA2559379A1 (fr) 2005-07-28
DE602005013912D1 (de) 2009-05-28
EP1710250B1 (fr) 2009-04-15
KR20070020204A (ko) 2007-02-20
ATE428722T1 (de) 2009-05-15
AU2005205314A1 (en) 2005-07-28
US20060258850A1 (en) 2006-11-16
CN1934128B (zh) 2011-01-26
JP4644604B2 (ja) 2011-03-02
CN1934128A (zh) 2007-03-21
AU2005205314B2 (en) 2010-12-09
EP1710250A1 (fr) 2006-10-11
EP1710250A4 (fr) 2007-07-11
US7531631B2 (en) 2009-05-12
WO2005068489A1 (fr) 2005-07-28

Similar Documents

Publication Publication Date Title
DK1710250T3 (da) Fremgangsmåde til fremstilling af humanserumalbumin ved varnebehandling i tilstedeværelse af divalt kation
ATE485517T1 (de) Verfahren zur identifizierung von polypeptid- targets
EA200602210A1 (ru) Связывающие молекулы, способные нейтрализовать вирус бешенства, и их применение
MX2007003166A (es) Hidantoinas sustituidas para el tratamiento del cancer.
MXPA05007182A (es) Complejos de cristales de proteina y polimeros ionicos.
HK1103746A1 (en) Antibodies to erythropoietin receptor and uses thereof
ATE552357T1 (de) Verfahren zur behandlung eines arsenhaltigen zwischenprodukts der schmelzerzeugung von nichteisenmetall
EA200970874A1 (ru) Антитела против склеростина
ATE494890T1 (de) Alpha-aminoamid-derivate zur behandlung von suchtstörungen
WO2006018188A3 (fr) Hydantoines substituees
NO20073300L (no) Glycintransportinhibitorer
EA201170312A1 (ru) Селективные антитела к гепцидину-25 и их применение
WO2006132739A3 (fr) Nouveaux composes chimiques
EA201390459A1 (ru) Способ обработки раствора, содержащего сульфат цинка
EA200801081A1 (ru) Способы лечения расстройств центральной нервной системы комбинацией малых доз эсциталопрама и бупропиона
WO2006131512A3 (fr) Agents antithrombiques
WO2004094651A3 (fr) Nouveaux polypeptides humains codes par des polynucleotides
WO2004075860A3 (fr) Procede de purification de l'acide zoledronique
WO2006127458A3 (fr) Nouveaux composes chimiques
WO2005074559A3 (fr) Procede pour separer des contaminants melanges a une poudre metallique de superalliage
ATE518003T1 (de) Verfahren zur identifizierung von cd4+-t-zellen- antigenen
DE602005003878D1 (de) Verfahren zur Herstellung von Gabapentin
WO2013052498A3 (fr) Inhibition de la caspase 9 et peptides bri2 dans le traitement de la démence
ATE556135T1 (de) Neues protein
EP1760087A4 (fr) Nouveau complexe proteinique et utilisation de ce complexe